Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers - Results of an experimental double blind placebo controlled study
E. Gouzoulis-mayfrank et al., Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers - Results of an experimental double blind placebo controlled study, PSYCHOPHAR, 142(1), 1999, pp. 41-50
The aim of this study was to contribute to the characterization of the enta
ctogen (ecstasy) substance group. The psychopathological, neuroendocrine an
d autonomic effects of common recreational doses of the entactogen 3,4-meth
ylenedioxyethylamphetamine (MDE), the hallucinogen psilocybin, the stimulan
t d-methamphetamine and placebo were investigated in a double-blind study w
ith healthy volunteers (n = 32). Psychological effects of the drugs were as
sessed by means of standardized rating scales, self assessment inventories
and free descriptions. The most characteristic effects of MDE were pleasant
emotional experiences of relaxation, peacefulness, content and closeness t
o others. However, significant stimulant and hallucinogen-like effects were
also present, although the latter were weaker than the effects of psilocyb
in. MDE elicited the strongest endocrine and autonomic effects among the th
ree drugs, including robust rises of serum cortisol and prolactin, elevatio
ns of blood pressure and heart rate, and a moderate, but significant rise o
f body temperature. The apparent contrast between psychological and autonom
ic effects (subjective relaxation versus physical activation) was a unique
feature of the MDE state. Our findings are in line with both users' reports
and results from previous experimental studies, and support the view that
entactogens constitute a distinct psychoactive substance class taking an in
termediate position between hallucinogens and stimulants.